Label: KILLA EXTRA STRENGTH 4 PACK- salicylic acid patch
- NDC Code(s): 81746-417-01
- Packager: ZitSticka, Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated June 13, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- WARNINGS
- ACTIVE INGREDIENT
- ASK DOCTOR
- KEEP OUT OF REACH OF CHILDREN
- PURPOSE
- DOSAGE & ADMINISTRATION
- INACTIVE INGREDIENT
- INDICATIONS & USAGE
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
KILLA EXTRA STRENGTH 4 PACK
salicylic acid patchProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:81746-417 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID 0.0125 mg in 0.6216 mg Inactive Ingredients Ingredient Name Strength OLIGOPEPTIDE-10 (UNII: Q46328TRNK) GLYCOLIC ACID (UNII: 0WT12SX38S) 4-BUTYLRESORCINOL (UNII: 2IK4UQ3ZGA) HYALURONATE SODIUM (UNII: YSE9PPT4TH) NIACINAMIDE (UNII: 25X51I8RD4) PHYTOSPHINGOSINE HYDROCHLORIDE (UNII: TT871XV7TU) MADECASSOSIDE (UNII: CQ2F5O6YIY) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:81746-417-01 3660 mg in 1 BOX; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.) 01/01/2023 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final M006 01/01/2023 Labeler - ZitSticka, Inc. (117778611) Establishment Name Address ID/FEI Business Operations Raphas 695914964 manufacture(81746-417)
